Q1 EPS Estimates for agilon health Lowered by William Blair

agilon health, inc. (NYSE:AGL) – Research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of agilon health in a note issued to investors on Tuesday, February 25th. William Blair analyst R. Daniels now expects that the company will earn $0.00 per share for the quarter, down from their previous forecast of $0.05. William Blair has a “Market Perform” rating on the stock. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.08) EPS and Q4 2026 earnings at ($0.13) EPS.

AGL has been the subject of several other research reports. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Sanford C. Bernstein raised their price objective on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a research report on Wednesday. Barclays reduced their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Finally, Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $3.95.

agilon health Price Performance

Shares of NYSE:AGL opened at $3.35 on Thursday. The business has a 50 day moving average price of $2.94 and a 200 day moving average price of $3.04. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -3.56 and a beta of 0.66. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

Hedge Funds Weigh In On agilon health

Institutional investors have recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in agilon health by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock valued at $1,516,000 after purchasing an additional 157,610 shares during the period. Two Sigma Advisers LP boosted its position in shares of agilon health by 4,393.5% during the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock worth $914,000 after purchasing an additional 470,100 shares in the last quarter. Two Sigma Investments LP grew its holdings in shares of agilon health by 73.7% in the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock valued at $1,630,000 after buying an additional 363,855 shares during the period. State of Wyoming grew its holdings in shares of agilon health by 89.3% in the 4th quarter. State of Wyoming now owns 122,504 shares of the company’s stock valued at $233,000 after buying an additional 57,802 shares during the period. Finally, Point72 Asset Management L.P. acquired a new position in shares of agilon health in the 4th quarter valued at $768,000.

Insider Activity at agilon health

In other news, Director John William Wulf bought 45,000 shares of the stock in a transaction dated Thursday, December 5th. The stock was bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 77,500 shares of company stock valued at $169,600 in the last three months. Corporate insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.